CYT Historical Earnings image   This CYT historical earnings page last updated 5/12/2023
CYT Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20235/10/2023NA
Q4 20223/23/2023NA
Q3 202211/7/2022NA
Q2 20228/8/2022NA
Q1 20225/5/2022NA
Q4 20213/16/2022NA
Q3 202111/12/2021NA
Q2 20218/9/2021NA
Q3 201510/22/2015497.00M
Q2 20157/16/2015508.20M
Q1 20154/16/2015515.00M
Q4 20141/27/2015485.00M
Q3 201410/16/20145.07M
Q2 20147/17/2014525.00M
Q1 20144/22/2014489.00M
Q4 20131/30/2014480.00M
Q3 201310/17/2013464.00M
Q2 20137/18/20130.51B
Q1 20134/18/2013477.40M
Q4 20121/31/2013470.70M
Q3 201210/18/2012455.40M
Q2 20127/19/20120.40B
Q1 20124/19/2012378.10M
CYT Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20235/10/2023-0.350
Q4 20223/23/2023-0.250
Q3 202211/7/2022-0.310
Q2 20228/8/2022-0.340
Q1 20225/5/2022-0.400
Q4 20213/16/2022-0.340
Q3 202111/12/2021-0.330
Q2 20218/9/2021-4.830
Q3 201510/22/20150.9
Q2 20157/16/20150.81
Q1 20154/16/20150.82
Q4 20141/27/20150.66
Q3 201410/16/20140.74
Q2 20147/17/20141.71
Q1 20144/22/20141.42
Q4 20131/30/20141.15
Q3 201310/17/20131.34
Q2 20137/18/20130.810
Q1 20134/18/20130.73
Q4 20121/31/20130.72
Q3 201210/18/20120.91
Q2 20127/19/20121.55
Q1 20124/19/20120.57
Quotes delayed 20 minutes

Email EnvelopeFree CYT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cyteir Therapeutics (CYT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CYTH Historical Earnings
CYTK Historical Earnings
DARE Historical Earnings
DAWN Historical Earnings
DBTX Historical Earnings
DCGO Historical Earnings
DCPH Historical Earnings
DCTH Historical Earnings
DERM Historical Earnings
DFFN Historical Earnings
What was the record high CYT historical earnings result?
In terms of earnings or revenue, what is the best CYT historical earnings result that Cyteir Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CYT historical earnings result was set in Q2 2014, when Cyteir Therapeutics posted results of 1.71/share. The most successful revenue quarter within our data set was Q2 2014 when Cyteir Therapeutics reported revenue of 525.00M.

What was the lowest Cyteir Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CYT has reported, and when?

✔️Accepted answer: Within our data set, the lowest CYT historical earnings result was set in Q2 2021, when Cyteir Therapeutics posted results of -4.830/share. The smallest revenue quarter within our data set was Q1 2023 when Cyteir Therapeutics reported revenue of NA.

On this page we presented the CYT historical earnings date information for Cyteir Therapeutics. Reviewing that CYT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2014, when CYT posted gaap of 1.71/share. Meanwhile the lowest CYT historical earnings result was in Q2 2021, when CYT posted gaap of -4.830/share. Moving to Cyteir Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2014 when CYT reported 525.00M in revenue, while the smallest revenue quarter was Q1 2023 when CYT reported NA in revenue.

For self directed investors doing their due diligence on CYT or any other given stock, their research can benefit from looking into all of the Cyteir Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Cyteir Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CYT. Thanks for visiting, and the next time you need to research CYT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding USMC, MTCH YTD Return, Institutional Holders of ULVM.


CYT Historical Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.